戻る Agenda
Asia-3 : Advancing Patient-Focused Drug Development: From Clinical Trials to Real-World Medication Use
Session Chair(s)
Ling Su, PhD
Research Fellow, Yeehong Business School, China
Speaker(s)
Su Lin Dorothy Toh, PhD
Asst Group Director, Health Products Regulation Group, Health Sciences Authority, Singapore
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
Kyu-Pyo Kim, MD, PhD
Professor, Department of Oncology, Asan Medical Center, Korea, Republic of
Wenjing ZHOU
, Hong Kong university shenzhen hospital, China